UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000027775
Receipt number R000031829
Scientific Title Prospective multicenter study regarding the efficacy of Gemcitabine (gemzar) plus nab-Paclitaxel (Abraxane) regimen for locally advanced pancreatic cancer
Date of disclosure of the study information 2017/07/01
Last modified on 2021/12/18 10:28:17

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Prospective multicenter study regarding the efficacy of Gemcitabine (gemzar) plus nab-Paclitaxel (Abraxane) regimen for locally advanced pancreatic cancer

Acronym

GEAR study

Scientific Title

Prospective multicenter study regarding the efficacy of Gemcitabine (gemzar) plus nab-Paclitaxel (Abraxane) regimen for locally advanced pancreatic cancer

Scientific Title:Acronym

GEAR study

Region

Japan


Condition

Condition

pancreatic cancer

Classification by specialty

Hepato-biliary-pancreatic medicine Hepato-biliary-pancreatic surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To analyze the efficacy of Gemcitabine/nab-Paclitaxel regimen for locally advanced pancreatic cancer with arterial invasion

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase

Phase II


Assessment

Primary outcomes

R0 resection rate

Key secondary outcomes

QOL assessment, Effectiveness of preoperative chemotherapy, pathological response rate, incidence rate of adverse events, relative dose intensity


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine Maneuver

Interventions/Control_1

Gemcitabine + nab-Paclitaxel regimen (Gemcitabine 1000mg/m2 nab-Panclitaxicel 125mg/2: day1,8,15 28day/course:2-4 course) and operation

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

75 years-old >

Gender

Male and Female

Key inclusion criteria

1) Histologically confirmed adenocarcinoma or adenosquamous carcinoma
2) BR-A pancreatic cancer
3) With measurable lesion(s)
4) Without distant metastasis
5) Without any further treatment for pancreatic cancer
6) Age more than 20 or less than 75
7)ECOG Performance Status 0-1
8) Without history of chemotherapy or radiotherapy
9)Adequate organ function
10) Sensory/motor neuropathy: None or Grade 1
11) Written informed consent

Key exclusion criteria

1) Present or previous (within 5 years) double cancer except for carcinoma in situ
2) Pregnant females, possibly pregnant females, females feeding babies and males wishing partners' pregnancy
3) Active infection
4) Severe mental disorder
5) Interstitial pneumonia or pulmonary fibrosis
6) Severe heart disease, liver disease and uncontrolled diabetes
7) Patients positive for HBs antigen
8) Patients inadequate for enhanced CT scan
9) Severe allergy for drugs
10) Patients with inadequate condition

Target sample size

37


Research contact person

Name of lead principal investigator

1st name Masafumi
Middle name
Last name Nakamura

Organization

Kyushu University

Division name

Department of Surgery and Oncology

Zip code

812-8582

Address

3-1-1 Maidashi, Higashi-ku, Fukuoka

TEL

092-622-5441

Email

mnaka@surg1.med.kyushu-u.ac.jp


Public contact

Name of contact person

1st name Yoshihiro
Middle name
Last name Miyasaka

Organization

Kyushu University

Division name

Department of Surgery and Oncology

Zip code

812-8582

Address

3-1-1 Maidashi, Higashi-ku, Fukuoka

TEL

092-622-5441

Homepage URL


Email

yoshi-m@surg1.med.kyushu-u.ac.jp


Sponsor or person

Institute

Kyushu-Yamaguchi study group of therapy for pancreatobiliary cancer

Institute

Department

Personal name



Funding Source

Organization

Self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Department of Surgery and Oncology, Kyushu University

Address

3-1-1 Maidashi, Higashi-ku, Fukuoka

Tel

0926425441

Email

yoshi-m@surg1.med.kyushu-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 07 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

37

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 06 Month 16 Day

Date of IRB

2017 Year 10 Month 13 Day

Anticipated trial start date

2017 Year 07 Month 20 Day

Last follow-up date

2020 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 06 Month 15 Day

Last modified on

2021 Year 12 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031829


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name